Amylyx Pharmaceuticals Files 8-K on Security Holder Votes
Ticker: AMLX · Form: 8-K · Filed: Jun 5, 2025 · CIK: 1658551
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
Related Tickers: AMLX
TL;DR
Amylyx (AMLX) filed an 8-K for a shareholder vote meeting on June 5th.
AI Summary
Amylyx Pharmaceuticals, Inc. filed an 8-K on June 5, 2025, to report on the submission of matters to a vote of security holders. The filing does not contain specific details about the matters to be voted on or any associated financial implications.
Why It Matters
This filing indicates that Amylyx Pharmaceuticals is convening a meeting for its security holders to vote on certain matters, which could potentially impact corporate governance or strategic decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new material financial information or significant corporate events.
Key Players & Entities
- Amylyx Pharmaceuticals, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of Report
FAQ
What specific matters are being submitted for a vote by Amylyx Pharmaceuticals' security holders?
The filing states that matters are being submitted to a vote of security holders, but it does not specify what those matters are.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 5, 2025.
What is the principal executive office address for Amylyx Pharmaceuticals, Inc.?
The principal executive office address is 43 Thorndike St., Cambridge, MA 02141.
What is the SEC file number for Amylyx Pharmaceuticals, Inc.?
The SEC file number for Amylyx Pharmaceuticals, Inc. is 001-41199.
What is the Standard Industrial Classification (SIC) code for Amylyx Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Amylyx Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 5, 2025 regarding Amylyx Pharmaceuticals, Inc. (AMLX).